AFP and neoplasm: Furthermore, in our analysis, tumor age according to the BCLC system and the tumor marker AFP were relevant risk factors for survival, whereas higher age was not associated with impaired survival, either in the cohort of patients who had undergone TACE or in the subgroup of patients receiving systemic therapy.